Rocket Pharmaceuticals Highlights Clinical Data from RP-A501 Trial in Danon Disease

  • Jonathan Schwartz,

Press/Media

Period21 Sep 2021

Media coverage

1

Media coverage

  • TitleRocket Pharmaceuticals Highlights Clinical Data from RP-A501 Trial in Danon Disease
    Media name/outletProfessional Services Close-Up
    Country/TerritoryUnited States
    Date21/09/21
    PersonsJonathan Schwartz,